This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Oct:57 Suppl 10:S116-S128.

doi: 10.1002/jcph.983.

Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future

Diane R Mould¹, Paul R Hutson²

Affiliations

PMID: 28921645
DOI: 10.1002/jcph.983

Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future

Diane R Mould et al. J Clin Pharmacol. 2017 Oct.

. 2017 Oct:57 Suppl 10:S116-S128.

doi: 10.1002/jcph.983.

Authors

Diane R Mould¹, Paul R Hutson²

Affiliations

¹ Projections Research, Phoenixville, PA, USA.
² University of Wisconsin-Madison, Madison, WI, USA.

PMID: 28921645
DOI: 10.1002/jcph.983

No abstract available

Keywords: anticancer; dosing; exposure/response; pharmacodynamics; population modeling; review; simulation.

PubMed Disclaimer

Similar articles

The historical development of cancer chemotherapy.
Burchenal JH. Burchenal JH. Semin Oncol. 1977 Jun;4(2):135-46. Semin Oncol. 1977. PMID: 327552 Review. No abstract available.
Emil Frei III, 1924-2013.
Holland JF, Freireich EJ. Holland JF, et al. J Clin Oncol. 2013 Oct 20;31(30):3727-30. doi: 10.1200/JCO.2013.51.8126. Epub 2013 Sep 9. J Clin Oncol. 2013. PMID: 24019548 No abstract available.
Hiroshi Maeda--defining the pathway to targeted cancer therapy.
Duncan R, Seymour L. Duncan R, et al. J Drug Target. 2007 Aug-Sep;15(7-8):456. doi: 10.1080/10611860701505940. J Drug Target. 2007. PMID: 17671891 No abstract available.
Adventures with an enigmatic anticancer drug.
Colvin OM. Colvin OM. Cancer Biol Ther. 2003 May-Jun;2(3):301-3. doi: 10.4161/cbt.2.3.392. Cancer Biol Ther. 2003. PMID: 12878871 No abstract available.
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years?
Alessio E, Messori L. Alessio E, et al. Met Ions Life Sci. 2018 Feb 5;18:/books/9783110470734/9783110470734-007/9783110470734-011.xml. doi: 10.1515/9783110470734-011. Met Ions Life Sci. 2018. PMID: 29394024 Review.

See all similar articles

Cited by

The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.
Buclin T, Thoma Y, Widmer N, André P, Guidi M, Csajka C, Decosterd LA. Buclin T, et al. Front Pharmacol. 2020 Mar 3;11:177. doi: 10.3389/fphar.2020.00177. eCollection 2020. Front Pharmacol. 2020. PMID: 32194413 Free PMC article. Review.
Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings.
Yin W, Gao C, Xu Y, Li B, Ruderfer DM, Chen Y. Yin W, et al. AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:237-246. eCollection 2018. AMIA Jt Summits Transl Sci Proc. 2018. PMID: 29888080 Free PMC article.
Molecular View on the iRGD Peptide Binding Mechanism: Implications for Integrin Activity and Selectivity Profiles.
D'Amore VM, Donati G, Lenci E, Ludwig BS, Kossatz S, Baiula M, Trabocchi A, Kessler H, Di Leva FS, Marinelli L. D'Amore VM, et al. J Chem Inf Model. 2023 Oct 23;63(20):6302-6315. doi: 10.1021/acs.jcim.3c01071. Epub 2023 Oct 3. J Chem Inf Model. 2023. PMID: 37788340 Free PMC article.
Design and Analysis of a Sample-and-Hold CMOS Electrochemical Sensor for Aptamer-based Therapeutic Drug Monitoring.
Chien JC, Baker SW, Soh HT, Arbabian A. Chien JC, et al. IEEE J Solid-State Circuits. 2020 Nov;55(11):2914-2929. doi: 10.1109/jssc.2020.3020789. Epub 2020 Sep 16. IEEE J Solid-State Circuits. 2020. PMID: 33343021 Free PMC article.
Exposure-response modeling improves selection of radiation and radiosensitizer combinations.
Cardilin T, Almquist J, Jirstrand M, Zimmermann A, Lignet F, El Bawab S, Gabrielsson J. Cardilin T, et al. J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):167-178. doi: 10.1007/s10928-021-09784-7. Epub 2021 Oct 8. J Pharmacokinet Pharmacodyn. 2022. PMID: 34623558 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal